Iovance grants inducement stock options for 179,750 shares at $10.02 each

Iovance Biotherapeutics granted inducement stock options covering 179,750 shares to 18 new, non-executive employees on Sept. 17, 2026. Options carry an exercise price of $10.02, set at the stock’s closing price on the grant date. Vesting runs over three years, with one-third on the first anniversary of the start date. Remaining shares vest in eight quarterly installments over the following two years, contingent on continued employment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iovance Biotherapeutics Inc. published the original content used to generate this news brief via (Ref. ID: 202609181710PRIMZONEFULLFEED9829743) on September 18, 2026, and is solely responsible for the information contained therein. (C)